Harbour Capital Advisors, LLC Abbott Laboratories Transaction History

Harbour Capital Advisors, LLC

$415 Million
Q3 2024

A detailed history of Harbour Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 7,776 shares of ABT stock, worth $918,578. This represents 0.21% of its overall portfolio holdings.

Number of Shares

7,776

Previous 7,776 -0.0%

Holding current value

$918,578

Previous $808,000 9.65%

% of portfolio

0.21%

Previous 0.2%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$100.78 - $112.29 $3,224 - $3,593	-32 Reduced 0.41%	7,776 $847,000
Q2 2022 Jul 20, 2022	SELL	$102.07 - $123.37 $12,248 - $14,804	-120 Reduced 1.51%	7,808 $848,000
Q4 2021 Jan 12, 2022	SELL	$115.53 - $141.46 $5,776 - $7,073	-50 Reduced 0.63%	7,928 $1.12 Million
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $18,198 - $20,133	156 Added 1.99%	7,978 $942,000
Q1 2021 Apr 12, 2021	BUY	$108.84 - $128.23 $851,346 - $1 Million	7,822 New	7,822 $937,000
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $868,980 - $946,939	-8,276 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $49,513 - $53,687	-605 Reduced 6.81%	8,276 $692,000
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $102,641 - $124,093	-1,550 Reduced 14.86%	8,881 $710,000
Q4 2018 Jan 23, 2019	BUY	$65.56 - $74.27 $2,950 - $3,342	45 Added 0.43%	10,431 $754,000
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $3,648 - $4,401	60 Added 0.58%	10,386 $762,000
Q1 2018 Apr 18, 2018	SELL	$56.27 - $63.62 $28,135 - $31,810	-500 Reduced 4.62%	10,326 $619,000
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $2,630 - $2,816	-49 Reduced 0.45%	10,826 $618,000
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $522,652 - $583,335	10,875	10,875 $580,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.

Account

Harbour Capital Advisors, LLC Abbott Laboratories Transaction History